Acelyrin, Inc. SLRN 深 沪
已收盘 05-21 16:00:00 美东时间
2.27
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.27
- 总市值 2.29亿
- 52周最高 7.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.845
- 委 比 0.00%
- 总股本 1.01亿
- 历史最高 29.88
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.845
- 每 手 1
- 风险率 1.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ACELYRIN Completes Merger and Delists from Nasdaq
ACELYRIN, INC. ( ($SLRN) ) has shared an announcement. On May 21, 2025, ACELYRI...
05-21 21:48
ACELYRIN Stockholders Approve Merger with Alumis
The latest announcement is out from ACELYRIN, INC. ( ($SLRN) ). ACELYRIN, INC.,...
05-20 04:55
Lumis Stockholders Approve All Proposals Required To Be Approved In Connection With Pending Merger With ACELYRIN; Merger Is Expected To Close In Q2 2025
lumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated
05-14 01:03
Alumis, ACELYRIN amend proposed merger pact
Alumis (NASDAQ:ALMS) and ACELYRIN (NASDAQ:SLRN) have updated their merger agreement, which now specifies new terms for the exchange of shares. According to the revised agreement, ACELYRIN shareholder...
04-21 19:29
Acelyrin adopts poison pill as Tang Capital Partners raises stake
Acelyrin (NASDAQ:SLRN) announced Thursday a decision to adopt a limited-duration stockholder rights plan, also known as a poison pill, after Tang Capital Partners rapidly accumulated 8.8% of the compa...
03-13 20:02
Acelyrin falls as Acelyrin reaffirms deal commitment
Acelyrin (NASDAQ:SLRN) traded sharply lower on Tuesday after the company and its California-based rival Alumis (NASDAQ:ALMS) reaffirmed their commitment to merge in line with their previously disclose...
03-04 22:37
Top-rated biotechs with negative enterprise values
After four consecutive years of underperformance, biotech stocks are among the most unloved segments in the market. Major industry benchmarks SPDR S&P Biotech ETF (NYSEARCA:XBI) and the iShares Biotec...
03-02 03:28
Key deals this week: Howard Hughes, Shift4 Payments, Herc Holdings, Celsius and more
Here's a list of key deals reported this week across sectors: Howard Hughes (NYSE:HHH) shares retreated 8% on Wednesday late morning trading, wiping out Tuesday's 6.8% gain, after confirming a revised...
02-23 04:35
Acelyrin jumps 11% on acquisition offer from Concentra Biosciences
Acelyrin (NASDAQ:SLRN) received an unsolicited acquisition offer from Concentra Biosciences, controlled by Tang Capital Partners. The proposal includes a cash payment of $3.00 per share, along with a ...
02-21 14:11
Alumis and Acelyrin to merge in all-stock deal
Alumis (ALUM) shares plunged ~17% in the premarket on Friday after the immunology-focused biopharma agreed to merge with its California-based rival Acelyrin (NASDAQ:SLRN) in an all-stock transaction. ...
02-07 19:47
